HOME > ARCHIVE

ARCHIVE

PHARMA DELEGATES

January 30, 2006
NEW PRODUCTS

January 30, 2006
PhRMA Announces Mr Ira Wolf as New Japan Representative

January 30, 2006
REGULATORY NEWS IN BRIEF

January 30, 2006
Early Approval of 4 Products Urged by Council

January 30, 2006
JPA Prefers Sweeping but Shallow Revision of Dispensing Fees

January 23, 2006
Replidyne Files for Approval of Faropenem in US: Daiichi Asubio

January 23, 2006
FY2006 Medical Fee Reform Proposal Taking Shape

January 23, 2006
Kyowa Hakko Licenses Anticancer Agent to Eli Lilly

January 23, 2006
REPORTER'S EYE

January 23, 2006
Meiji Seika Aims for Generic Sales of \10 Bil. by FY2008

January 23, 2006
MEDICAL DEVICE NEWS IN BRIEF

January 23, 2006
40% of FD Patients Complain of Abdominal Distention

January 23, 2006
3 New Procedures to Be Covered by Insurance in April

January 23, 2006
R&D NEWS IN BRIEF

January 23, 2006
NEW PRODUCTS

January 23, 2006
TOPICS 3 articles

January 23, 2006
JPMA Approves FY2006 Action Plan

January 23, 2006
Review Process Will Be Speeded Up in 2nd Half of FY2006: PMDA Director Miyajima

January 23, 2006
SEMINAR

January 23, 2006

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

Japan’s FY2026 R&D Tax Credit Reform Wins Broad Industry Backing

By Sakura Kono

Japan will overhaul its R&D tax credit regime in its FY2026 reform, introducing a new strategic category alongside existing frameworks.…

COLUMN

Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing

By Philip Carrigan

Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…